SCHEMBL8311581

SCHEMBL8311581

CCOc1ccc(C=C2SC(=S)NC2=O)cc1OCC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 6/20 1.00
PDE3A Q14432 5/20 1.00
MEN1 O00255 3/20 0.88
KMT2A Q03164 3/20 0.88
DYRK1A Q13627 2/20 0.88
ALDH1A1 P00352 2/20 0.88
MAPT P10636 2/20 0.88
LMNA P02545 1/20 0.88
NPSR1 Q6W5P4 1/20 0.88
PIM1 P11309 1/20 0.80
PIM3 Q86V86 1/20 0.80
DYRK2 Q92630 1/20 0.80
PIM2 Q9P1W9 1/20 0.80
MGAM O43451 1/20 0.75
GAA P10253 1/20 0.75
SI P14410 1/20 0.75
MGAM2 Q2M2H8 1/20 0.75
ADAMTS5 Q9UNA0 3/20 0.71
IGF1R P08069 3/20 0.70
POLB P06746 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8311580 1.00 PDE4B (1.00) PDE4BPDE3AMEN1KMT2ADYRK1A
SCHEMBL8310975 0.94 PDE4B (0.89) PDE4BPDE3AMEN1KMT2ADYRK1A
SCHEMBL8310978 0.94 PDE4B (0.89) PDE4BPDE3AMEN1KMT2ADYRK1A
SCHEMBL8306525 0.94 PDE4B (0.89) PDE4BPDE3AMEN1KMT2ADYRK1A
SCHEMBL8306523 0.94 PDE4B (0.89) PDE4BPDE3AMEN1KMT2ADYRK1A
SCHEMBL8307072 0.94 PDE4B (1.00) PDE4BPDE3AMEN1KMT2ADYRK1A
SCHEMBL8308532 0.94 PDE4B (1.00) PDE4BPDE3AMEN1KMT2ADYRK1A
SCHEMBL8307071 0.94 PDE4B (1.00) PDE4BPDE3AMEN1KMT2ADYRK1A
SCHEMBL8308535 0.94 PDE4B (1.00) PDE4BPDE3AMEN1KMT2ADYRK1A
SCHEMBL8308760 0.93 PDE4B (0.87) PDE4BPDE3AMEN1KMT2ADYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5661168-A ADMINISTERING RHODANINE DERIVATIVES TO CONTROL DIABETES ELI LILLY AND COMPANY (US) 1997-08-26 US claimed
EP-0915090-A1 Compounds useful as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1999-05-12 EP disclosed
US-5716975-A NONTOXIC RHODANINE DERIVATIVES; ANTIDIABETIC AGENTS, CATHEPSIN D INHIBITORS, B-AMYLOID PROTEIN REDUCTION ELI LILLY AND COMPANY (US) 1998-02-10 US disclosed
US-5661168-A ADMINISTERING RHODANINE DERIVATIVES TO CONTROL DIABETES ELI LILLY AND COMPANY (US) 1997-08-26 US disclosed
US-5523314-A RHODANINE DERIVATIVES ELI LILLY AND COMPANY (US) 1996-06-04 US disclosed
CN-1091006-A Chemical compound as blood sugar lowering and treatment degenerative brain disorder LILLY CO ELI (US) 1994-08-24 CN disclosed
EP-0587377-A2 Thiazolidinone derivatives as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1994-03-16 EP disclosed
EP-0139464-B1 BENZOTHIOPHENE DERIVATES AS BRONCHODILATORS ELI LILLY AND COMPANY (US) 1988-10-19 EP disclosed
US-4552891-A BRONCHODILATOR ELI LILLY AND COMPANY (US) 1985-11-12 US disclosed
EP-0139464-A1 Benzothiophene derivates as bronchodilators ELI LILLY AND COMPANY (US) 1985-05-02 EP disclosed